This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of John S. Stahl
Introduction
John S. Stahl is a notable inventor based in Shaker Heights, OH (US). He has made significant strides in the field of ocular mobility disorders through his innovative inventions. His work focuses on developing non-invasive treatment devices that address complex eye movement issues.
Latest Patents
Stahl holds a patent for an "Acquired Pendular Nystagmus Treatment Device." This device is designed to treat eye movement disorders by utilizing servo-controlled prisms. It is wearable and operates in a non-invasive and non-pharmacologic manner. The device includes an eye movement sensor and oscillates the perceived image in sync with pathological nystagmus, effectively negating its harmful effects. Importantly, it only targets abnormal eye movements, allowing normal reflexive movements to remain unaffected. Beyond acquired pendular nystagmus (APN), the device has potential applications for treating other ocular mobility disorders, including jerk nystagmus and strabismus.
Career Highlights
Throughout his career, John S. Stahl has demonstrated a commitment to advancing medical technology. His innovative approach to treating eye movement disorders has garnered attention in the medical community. With a focus on improving patient outcomes, his work exemplifies the intersection of technology and healthcare.
Collaborations
Stahl has collaborated with talented individuals such as Kelvin Wu and Bennett Curtis Burke. These partnerships have contributed to the development and refinement of his innovative devices.
Conclusion
John S. Stahl's contributions to the field of ocular mobility disorders through his patented device highlight the importance of innovation in healthcare. His work not only addresses specific medical challenges but also paves the way for future advancements in non-invasive treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile